Solid Tumors and Kinase Inhibition: Management and Therapy Efficacy Evolution
The increasing numbers of cancer cases worldwide and the exceedingly high mortality rates of some tumor subtypes raise the question about if the current protocols for cancer management are effective and what has been done to improve upon oncologic patients’ prognoses. The traditional chemo-immunothe...
Main Authors: | Flávia Melo Cunha de Pinho Pessoa, Caio Bezerra Machado, Emerson Lucena da Silva, Laudreísa da Costa Pantoja, Rodrigo Monteiro Ribeiro, Maria Elisabete Amaral de Moraes, Manoel Odorico de Moraes Filho, Raquel Carvalho Montenegro, André Salim Khayat, Caroline Aquino Moreira-Nunes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/7/3830 |
Similar Items
-
Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations
by: Caio Bezerra Machado, et al.
Published: (2021-10-01) -
The Role of WRAP53 in Cell Homeostasis and Carcinogenesis Onset
by: Renan Brito Gadelha, et al.
Published: (2022-11-01) -
Kinase Inhibition in Multiple Myeloma: Current Scenario and Clinical Perspectives
by: Igor Valentim Barreto, et al.
Published: (2022-08-01) -
Leukemic Stem Cell: A Mini-Review on Clinical Perspectives
by: Igor Valentim Barreto, et al.
Published: (2022-06-01) -
Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment
by: Mahdie Rahban, et al.
Published: (2024-01-01)